BigBearPharma 中文中文
Skip to content
  • About Us
    • About
    • Business Strategy
    • Managemt Team
    • Board of Directors
    • Investors
  • Therapeutic Areas
    • Adral Insufficicy
    • Cystic Fibrosis
    • Lysosomal Storage Disorders
    • Osteoporosis
    • Adrenocortical Tumor
    • Moderate to Severe Rheumatoid Arthritis
  • Products & Pipeline
    • Products
      • ENASIDX (Enasidenib) 50mg
      • ELTROMDX (Eltrombopag) 50mg
      • CAPIVADX (Capivasertib) 200 mg
      • CAPIVADX (Capivasertib) 160mg
      • PONADX (Ponatinib) 15mg/45mg
      • BRIGADX (Brigatinib) 90 mg / 180 mg
      • RITEDX (Ritlecitinib)
      • ASIDX (Axitinib)
      • SODADX (Sofosbuvir/Velpatasvir)
      • POMMADX,Pomalidomide,4mg
    • Anticancer
      • OLADX，Olaparib，150mg
      • WELIDX, Belzutifan
      • VEMUDX，vemurafenib
      • AILEDX, Alectinib, 150mg
      • APADX, Apalutamide
      • KESODX，Crizotinib
      • TEPODX，Tepotinib
      • REPODX，Repotrectinib
      • BRATODX，Encorafenib
      • LENVIDX,Lenvatinib
    • Generic Drugs
      • FEBUSODX, Febuxostat
      • LUTRODX，Lusutrombopag，3mg
      • TOFADX,Tofacitinib,11mg
      • BARUDX, Baricitinib,2mg
      • BARUDX, Baricitinib,4mg
      • TEGLIDX，Trelagliptin 100mg
      • UPADX，Upadacitinib 15mg
      • TOFADX，Tofacitinib 5mg
      • DUVACIDX, Deucravacitinib 6mg
      • ELTROMDX, Eltrombopag 25mg
    • Antiviral
      • TENODX, Tenofovir Alafenamide, 25mg
      • LETEDX,Letermovir,240mg
  • Business Developmt
    • Rare Diseases
    • Affiliations
  • Newsroom
    • New Products
    • Disease News
    • Firm News
  • Contact
Skip to content
  • About Us
    • About
    • Business Strategy
    • Managemt Team
    • Board of Directors
    • Investors
  • Therapeutic Areas
    • Adral Insufficicy
    • Cystic Fibrosis
    • Lysosomal Storage Disorders
    • Osteoporosis
    • Adrenocortical Tumor
    • Moderate to Severe Rheumatoid Arthritis
  • Products & Pipeline
    • Products
      • ENASIDX (Enasidenib) 50mg ®
      • ELTROMDX (Eltrombopag) 50mg®
      • CAPIVADX (Capivasertib) 200 mg ®
      • CAPIVADX (Capivasertib) 160mg®
      • PONADX (Ponatinib) 15mg/45mg®
      • BRIGADX (Brigatinib) 90 mg / 180 mg®
      • RITEDX (Ritlecitinib)®
      • ASIDX (Axitinib)®
      • SODADX (Sofosbuvir/Velpatasvir)®
      • POMMADX,Pomalidomide,4mg®
    • Anticancer
      • OLADX，Olaparib，150mg®
      • WELIDX, Belzutifan®
      • VEMUDX，vemurafenib®
      • AILEDX, Alectinib, 150mg®
      • APADX, Apalutamide®
      • KESODX，Crizotinib®
      • TEPODX，Tepotinib®
      • REPODX，Repotrectinib®
      • BRATODX，Encorafenib®
      • LENVIDX,Lenvatinib®
    • Generic Drugs
      • FEBUSODX, Febuxostat®
      • LUTRODX，Lusutrombopag，3mg®
      • TOFADX,Tofacitinib,11mg®
      • BARUDX, Baricitinib,2mg®
      • BARUDX, Baricitinib,4mg®
      • TEGLIDX，Trelagliptin 100mg®
      • UPADX，Upadacitinib 15mg®
      • TOFADX，Tofacitinib 5mg®
      • DUVACIDX, Deucravacitinib 6mg®
      • ELTROMDX, Eltrombopag 25mg®
    • Antiviral
      • TENODX, Tenofovir Alafenamide, 25mg®
      • LETEDX,Letermovir,240mg®
  • Business Developmt
    • Rare Diseases
    • Affiliations
  • Newsroom
    • New Products
    • Disease News
    • Firm News
  • Contact
  • 中文中文

Products & Pipeline

ENASIDX (Enasidenib) 50mg

ELTROMDX (Eltrombopag) 50mg

CAPIVADX (Capivasertib) 200 mg

CAPIVADX (Capivasertib) 160mg

PONADX (Ponatinib) 15mg/45mg

BRIGADX (Brigatinib) 90 mg / 180 mg

RITEDX (Ritlecitinib)

ASIDX (Axitinib)

SODADX (Sofosbuvir/Velpatasvir)

OLADX，Olaparib，150mg

WELIDX, Belzutifan

VEMUDX，vemurafenib
  • Home
  • Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next
  • Last

© 2023 BigBear Pharmaceuticals

Privacy Policy